A detailed history of Econ Financial Services Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Econ Financial Services Corp holds 26,159 shares of GILD stock, worth $2.36 Million. This represents 1.24% of its overall portfolio holdings.

Number of Shares
26,159
Previous 18,230 43.49%
Holding current value
$2.36 Million
Previous $1.25 Million 75.36%
% of portfolio
1.24%
Previous 0.78%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$66.59 - $83.99 $527,992 - $665,956
7,929 Added 43.49%
26,159 $2.19 Million
Q2 2024

Aug 12, 2024

BUY
$63.15 - $72.88 $243,506 - $281,025
3,856 Added 26.83%
18,230 $1.25 Million
Q1 2024

May 15, 2024

BUY
$71.58 - $87.29 $1.03 Million - $1.25 Million
14,374 New
14,374 $1.05 Million
Q3 2022

Oct 05, 2022

BUY
$59.54 - $68.01 $571,643 - $652,964
9,601 Added 21.18%
54,921 $3.39 Million
Q2 2022

Jul 19, 2022

SELL
$57.72 - $65.01 $4,329 - $4,875
-75 Reduced 0.17%
45,320 $2.8 Million
Q1 2022

Apr 22, 2022

BUY
$57.92 - $72.58 $1.08 Million - $1.36 Million
18,719 Added 70.17%
45,395 $2.7 Million
Q4 2021

Jan 26, 2022

BUY
$64.88 - $73.64 $1.35 Million - $1.53 Million
20,810 Added 354.76%
26,676 $1.94 Million
Q2 2019

Aug 08, 2019

BUY
$61.87 - $69.38 $86,494 - $96,993
1,398 Added 31.29%
5,866 $396,000
Q1 2019

May 08, 2019

BUY
$62.53 - $70.05 $36,705 - $41,119
587 Added 15.12%
4,468 $290,000
Q4 2018

Feb 07, 2019

BUY
$60.54 - $79.0 $234,955 - $306,599
3,881 New
3,881 $243,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Econ Financial Services Corp Portfolio

Follow Econ Financial Services Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Econ Financial Services Corp, based on Form 13F filings with the SEC.

News

Stay updated on Econ Financial Services Corp with notifications on news.